Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7310
+0.0006 (0.08%)
Oct 17, 2025, 4:00 PM EDT - Market closed
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $5.44 million as of October 20, 2025. Its market cap has increased by 6.14% in one year.
Market Cap
5.44M
Enterprise Value
-1.78M
1-Year Change
6.14%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $5.44M, a decrease of -91.67%. That is a compound annual growth rate of -45.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 5.44M | 36.40% |
Dec 31, 2024 | 3.99M | -48.26% |
Dec 29, 2023 | 7.71M | -58.92% |
Dec 30, 2022 | 18.77M | -51.55% |
Dec 31, 2021 | 38.74M | -40.66% |
Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 720.73B |
Johnson & Johnson | 465.34B |
AbbVie | 405.55B |
UnitedHealth Group | 322.96B |
AstraZeneca | 260.83B |
Novartis AG | 254.64B |
Novo Nordisk | 237.72B |
Abbott Laboratories | 223.72B |